Advertisement
Advertisement
GRFS
Grifois, S.A.
8.10
USDSponsored
+0.04
+0.50%
May 08, 15:58 UTC -4
Closed
After-Market
8.09
-0.01
-0.19%
GRFS Earnings Reports
Positive Surprise Ratio
GRFS beat 2 of 5 last estimates.
40%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.77B
/$0.13
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
-51.79%
/-53.57%
Grifois, S.A. earnings per share and revenue
On May 07, 2026, GRFS reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.13 USD, with revenue projected to reach 1.77 billion USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stevanato Group S.p.A.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.10
Actual
$0.11
Surprise
+5.45%
Nektar Therapeutics
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.62
Actual
-$1.82
Surprise
-11.88%
Definium Therapeutics, Inc. Common Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.71
Surprise
-41.43%
ZOETIS INC.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.63
Actual
$1.53
Surprise
-6.19%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.37
Surprise
-9.82%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$1.62
Actual
$1.76
Surprise
+8.43%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+296.08%
Nature's Sunshine Products Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.22
Actual
$0.30
Surprise
+30.72%
Akebia Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.03
Surprise
-4.90%
Organogenesis Holdings Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.37
Surprise
-17.01%
FAQ
What were Grifois, S.A.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Grifois, S.A. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Grifois, S.A.'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Grifois, S.A. expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for Grifois, S.A.'s next earnings report?
Based on --
analysts, Grifois, S.A. is expected to report EPS of $0.13 and revenue of $1.77B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement